DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/klnld9/global) has announced the addition of the "Global Epinephrine Autoinjector Market 2015-2019" report to their offering.
The analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.12 percent over the period 2014-2019.
Key Regions
- Americas
- APAC
- EMEA
Key Vendors
- ALK Abello
- Amedra Pharmaceuticals
- Lincoln Medical
- Mylan
- Sanofi
Other Prominent Vendors
- Adamis Pharmaceuticals
- Antares Pharma
- Hospira
- Intelliject
- Teva Pharmaceutical Industries
Commenting on the report, an analyst from the team said: One key trend upcoming in this market is the availability of improved injecting devices. Several advances in technology have been driving the market in the positive direction.
According to the report, the major driver in this market is the increase in the prevalence of allergies. Allergies to food items, food additives, dust, and insect venom have led to a rise in the usage of epinephrine drugs. Epinephrine works immediately and helps reduce the symptoms of a life-threatening allergy.
Further, the report states that the growth of the market is curtailed by a major challenge such as the availability of alternative treatment options. The many substitutes for these devices hamper the growth of this market.
For more information visit http://www.researchandmarkets.com/research/klnld9/global
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
